Table 6 Spearman correlation analysis of TG reduction and clinical data

Group

0.343***

< 0.001

Age

0.014

0.838

Female

0.016

0.813

BMI

0.391***

< 0.001

Hypertension

−0.049

0.474

Diabetes

−0.025

0.714

Coronary artery disease

0.130

0.059

Hyperlipidemia

0.093

0.176

Beta-blocker

0.014

0.838

Calcium channel blocker

−0.092

0.183

Diuretics

−0.058

0.405

Aldosterone antagonists

0.013

0.853

SGLT2-i

−0.078

0.256

Hormone

0.061

0.376

Ezetimibe

0.118

0.086

Statins

0.019

0.787

SBP

−0.083

0.230

DBP

−0.049

0.475

TC

−0.042

0.538

HDL-C

−0.131

0.056

LDL-C

−0.028

0.680

ApoA

0.006

0.934

ApoB

0.109

0.115

Albumin

0.025

0.717

Cystatin C

0.020

0.767

Urea

0.047

0.492

Creatine

−0.056

0.417

eGFR

0.035

0.615

Uric acid

0.001

0.984

FBG

0.046

0.508

HbA1c

0.233**

0.001

Potassium

0.034

0.621

High-sensitive troponin T

0.007

0.915

NT-proBNP

−0.048

0.488

LVEF

0.040

0.563

LVEDD

−0.036

0.605

LAD

0.014

0.837

NYHA class

−0.041

0.555